BACE1-AS, through different modes of action, not only enhances the stability of BACE1 mRNA but also promotes BACE1 mRNA expression, leading to increased Aβ1-42/Aβ1-40 production by APP via the amyloid processing pathway and accelerating the development of AD. This evidence concerns the gene APP and Alzheimer disease.